Scar Free And Painless Removal Of Benign Tumors Of Breast Now Available In India

Medanta – The Medicity, a multi-speciality institute located in National Capital Region, has introduced the ‘Scar Free Breast Biopsy’ treatment in India. The treatment ensures 99% scar free detection and removal of benign lumps. This new technology saves women from breast amputation and other causalities related to cancer, as early diagnosis of the disease is now possible.

TheWorld Health Organization (WHO) has predicted that by 2020, one in eight urban Indian women will develop breast cancer in her lifetime. Presently, one in four female cancer cases are breast cancers*. The disease is prevalent in India, claiming one in 28 urban women as victims.

About MRI – Guided Vacuum assisted Breast Biopsy (VABB)

Scar Free Breast Biopsy’ is also known as Guided Vacuum assisted Breast Biopsy (VABB). The biggest positive for the women undergoing this surgery is that it will not leave any ‘scar’ on the breast post the procedure. It offers very early diagnosis of really small abnormalities (as small as 1-2mm) which are not visualized on ultrasound or mammography and are only visible on MRI. Adequate samples of the lesions are collected, with its unique suction technology in a single prick of the needle that enhances the accuracy of the procedure.

Commenting on the announcement, Dr. Naresh Trehan, Founder and Chairman, Medanta - The Medicity said, “We are proud to bring yet another ground-breaking technology to India that relieves 49% of our population from the fear of after-effects of the breast cancer detection process. Women in India now have access to the international grade technology that delivers scar free detection and treatment of breast cancer.”

Dr. Jyoti Arora, who is a leading breast interventional radiologist in India and Sr Consultant Radiologist at Medanta the Medicity is a frequent user of this technology and she says, “This technology currently is the last stop for breast biopsy and is recommended specifically for difficult lesions when we can’t target them under other modalities like ultrasound and mammography. VABB technology increases the efficiency, accuracy and eases of targeting these breast lesions and is the standard of care in the Western world.”

“This technology is now being used to remove small benign (non-cancerous) breast lumps after careful patient selection. The whole procedure can be done under local anesthetic as an OPD procedure. The major advantages are: It is scar free, with quick healing time and no risk of general anesthesia,” Dr. Arora added.